Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?
Glunde
Kristine
K
JHU ICMIC Program, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. kglunde@mri.jhu.edu
Bhujwalla
Zaver M
ZM
D000418:Albumins; D000818:Animals; D001932:Brain Neoplasms / Q000175:diagnosis / Q000378:metabolism; D003287:Contrast Media; D004195:Disease Models, Animal; D019786:Gadolinium DTPA; D005910:Glioma / Q000175:diagnosis* / Q000378:metabolism*; D008279:Magnetic Resonance Imaging; D019859:Proto-Oncogene Proteins c-met / Q000378:metabolism*
D000418:Albumins; D003287:Contrast Media; C058946:albumin-(gadolinium-DTPA); D019859:Proto-Oncogene Proteins c-met; D019786:Gadolinium DTPA